Skip to main content
Erschienen in: Infection 1/2013

01.02.2013 | Clinical and Epidemiological Study

Duration of treatment for candidemia and risk for late-onset ocular candidiasis

verfasst von: O. Blennow, L. Tallstedt, B. Hedquist, B. Gårdlund

Erschienen in: Infection | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Few reports have been published on the optimal duration of treatment of ocular candidiasis. We have investigated the incidence of late-onset Candida chorioretinitis and endophthalmitis in patients with candidemia who did not initially receive an ophthalmologic examination. The aim was to determine the duration of initial antifungal treatment that may be sufficient to avoid this complication.

Methods

This was a long-term follow-up study of 144 patients with candidemia who survived for at least 60 days after the onset of candidemia. The frequency of early- and late-onset ocular complications due to candida infection and factors associated with ocular candidiasis were investigated.

Results

Fundoscopy was performed on 60 patients, revealing 12 cases of ocular candida infection (20 %). Risk factors were infection with Candida albicans compared to other Candida species (p = 0.021) and surgery due to solid tumor (p = 0.004). Only one case of late-onset ocular candidiasis occurred among the 84 candidemic patients who did not receive an initial ophthalmologic examination. For unknown reasons, this patient had received only 2 days of systemic antifungal treatment initially.

Conclusions

No case of late-onset ocular candidiasis was detected in unexamined patients who received at least 14 days of antifungal treatment. Based on our results, it would appear that the recommended 2 weeks of treatment after the first negative blood culture are sufficient to avoid late-onset complications due to undiscovered Candida chorioretinitis in patients surviving for more than 60 days after the onset of candidemia.
Literatur
1.
Zurück zum Zitat Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr., Calandra TF, Edwards JE, Jr., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.PubMedCrossRef Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr., Calandra TF, Edwards JE, Jr., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35.PubMedCrossRef
2.
Zurück zum Zitat Chalmers C, Gaur S, Chew J, Wright T, Kumar A, Mathur S, et al. Epidemiology and management of candidaemia: a retrospective, multicentre study in five hospitals in the UK. Mycoses. 2011;54:E795–800.PubMedCrossRef Chalmers C, Gaur S, Chew J, Wright T, Kumar A, Mathur S, et al. Epidemiology and management of candidaemia: a retrospective, multicentre study in five hospitals in the UK. Mycoses. 2011;54:E795–800.PubMedCrossRef
3.
Zurück zum Zitat Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53:262–8.PubMedCrossRef Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clin Infect Dis. 2011;53:262–8.PubMedCrossRef
4.
Zurück zum Zitat Rodriguez-Adrian LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine (Baltimore). 2003;82:187–202. Rodriguez-Adrian LJ, King RT, Tamayo-Derat LG, Miller JW, Garcia CA, Rex JH. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology. Medicine (Baltimore). 2003;82:187–202.
5.
Zurück zum Zitat Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.PubMedCrossRef Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.PubMedCrossRef
6.
Zurück zum Zitat Karmisholt MK, Hjort U, Knudsen LL, Schonheyder HC. Candidaemia and risk of intraocular infection: a Danish hospital-based cohort study. Scand J Infect Dis. 2008;40:241–6.PubMedCrossRef Karmisholt MK, Hjort U, Knudsen LL, Schonheyder HC. Candidaemia and risk of intraocular infection: a Danish hospital-based cohort study. Scand J Infect Dis. 2008;40:241–6.PubMedCrossRef
7.
Zurück zum Zitat Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE, Jr., et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101:1302–9.PubMed Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE, Jr., et al. Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology. 1994;101:1302–9.PubMed
8.
Zurück zum Zitat Edwards JE, Jr., Montgomerie JZ, Ishida K, Morrison JO, Guze LB. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis. 1977;135:294–7.PubMedCrossRef Edwards JE, Jr., Montgomerie JZ, Ishida K, Morrison JO, Guze LB. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. J Infect Dis. 1977;135:294–7.PubMedCrossRef
9.
Zurück zum Zitat Edwards JE Jr, Montgomerie JZ, Foos RY, Shaw VK, Guze LB. Experimental hematogenous endophthalmitis caused by Candida albicans. J Infect Dis. 1975;131:649–57.PubMedCrossRef Edwards JE Jr, Montgomerie JZ, Foos RY, Shaw VK, Guze LB. Experimental hematogenous endophthalmitis caused by Candida albicans. J Infect Dis. 1975;131:649–57.PubMedCrossRef
10.
Zurück zum Zitat Dellon AL, Stark WJ, Chretien PB. Spontaneous resolution of endogenous Candida endophthalmitis complicating intravenous hyperalimentation. Am J Ophthalmol. 1975;79:648–54.PubMed Dellon AL, Stark WJ, Chretien PB. Spontaneous resolution of endogenous Candida endophthalmitis complicating intravenous hyperalimentation. Am J Ophthalmol. 1975;79:648–54.PubMed
11.
Zurück zum Zitat Le Thien L, Fajnkuchen F, Chaine G. Candida chorioretinitis in drug addicts. Apropos of 2 cases. J Fr Ophtalmol. 1998;21:387–92.PubMed Le Thien L, Fajnkuchen F, Chaine G. Candida chorioretinitis in drug addicts. Apropos of 2 cases. J Fr Ophtalmol. 1998;21:387–92.PubMed
12.
Zurück zum Zitat Dozier CC, Tarantola RM, Jiramongkolchai K, Donahue SP. Fungal eye disease at a tertiary care center: the utility of routine inpatient consultation. Ophthalmology. 2011;118:1671–6.PubMedCrossRef Dozier CC, Tarantola RM, Jiramongkolchai K, Donahue SP. Fungal eye disease at a tertiary care center: the utility of routine inpatient consultation. Ophthalmology. 2011;118:1671–6.PubMedCrossRef
Metadaten
Titel
Duration of treatment for candidemia and risk for late-onset ocular candidiasis
verfasst von
O. Blennow
L. Tallstedt
B. Hedquist
B. Gårdlund
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 1/2013
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0369-8

Weitere Artikel der Ausgabe 1/2013

Infection 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.